Health News Recap

Health News Recap

Roger Collier | CMAJ | March 9, 2018 Buprenorphine-naloxone should be the “preferred first-line treatment” for opioid use disorders, recommends a national clinical practice guideline published in CMAJ. The guideline recommends against using withdrawal management alone...

Pin It on Pinterest